LeserbriefKommentar
Bleeding in Patients With Atrial Fibrillation
JAMA · 2024
DOI: 10.1001/jama.2024.13789 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Bethany T Samuelson Bannow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hemostasis and Thrombosis Center, Oregon Health & Science University, Portland. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Hemorrhage. Die Arbeit nennt 5 Literaturangaben. Gefördert von: NIAMS NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnticoagulantsAtrial FibrillationHemorrhageHumansStrokeDiltiazemDrug InteractionsSex FactorsMaleFemaleResearch DesignPractice Guidelines as Topic
Substanzen
AnticoagulantsDiltiazem
Autor:innen und Institutionen
- Hemostasis and Thrombosis Center, Oregon Health & Science University, Portland.
- Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland.
Förderung
- NIAMS NIH HHS
- NICHD NIH HHS
Zitieren
APA
Samuelson Bannow, B. T., Colwill, A., & Edelman, A. (2024). Bleeding in Patients With Atrial Fibrillation. JAMA. https://doi.org/10.1001/jama.2024.13789
Vancouver
Samuelson Bannow BT, Colwill A, Edelman A. Bleeding in Patients With Atrial Fibrillation. JAMA. 2024. doi:10.1001/jama.2024.13789
BibTeX
@article{SamuelsonBannow2024,
author = {Samuelson Bannow, Bethany T and Colwill, Alyssa and Edelman, Alison},
title = {Bleeding in Patients With Atrial Fibrillation},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.13789}
}
EUVIMED